NEVVI Medicare utilization intelligence

← back

MOUCH, CHARLESM.D. NPI 1851740583 Clinician

Pain Management · SAN MARCOS, TX

Specialty Pain Management — from billed Medicare claims
Trained UNIVERSITY OF TEXAS MEDICAL SCHOOL AT SAN ANTONIO — medical school, self-reported to CMS
In practice about 10 years since medical school (class of 2016, self-reported to CMS)
Location SAN MARCOS, TX · NPPES registered location
Active in data Billed Medicare 2021–2024 (4 consecutive years)
Scale 31 codes billed · 30,126 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20222026
CENTRAL TEXAS PAIN CENTER, PLLC
2022–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2023-03

Year: 2024 · 2023 · 2022  · 2021 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1010 Injection, methylprednisolone acetate, 1 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
64483 Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level
62323 Injection of substance into lower spine canal using imaging guidance
64493 Injection of lower or sacral spine facet joint using imaging guidance, single level
77002 Fluoroscopic guidance for needle placement
J1040 Injection, methylprednisolone acetate, 80 mg
64494 Injection of lower or sacral spine facet joint using imaging guidance, second level
62321 Injection of substance into middle or upper spine canal using imaging guidance
64490 Injection of upper or middle spine facet joint using imaging guidance, single level
64491 Injection of upper or middle spine facet joint using imaging guidance, second level
20610 Aspiration and/or injection of fluid from large joint
27096 Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance
64484 Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level
64635 Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint
64636 Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint
80307 Testing for presence of drug, by chemistry analyzers
J1030 Injection, methylprednisolone acetate, 40 mg
63650 Insertion of spinal neurostimulator electrode array through skin
J1020 Injection, methylprednisolone acetate, 20 mg
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
64633 Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint
64634 Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint
20611 Aspiration and/or injection of fluid large joint using ultrasound guidance
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
0275T Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin
20605 Aspiration and/or injection of fluid from medium joint
76942 Ultrasonic guidance for needle placement
64454 Injection of anesthetic agent and/or steroid into knee nerve branch using imaging guidance
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.